FAQs
Are magic mushrooms safe to use?
In our large-scale study of psilocybin use, adverse reactions were rare, with less than 1% of participants reporting seeking medical
In our large-scale study of psilocybin use, adverse reactions were rare, with less than 1% of participants reporting seeking medical
HPPD is a rare clinical condition that results in people experiencing visual and perceptual distortions days, months, or even years
In his seminal book titled Animals and Psychedelics, Italian researcher, and expert in zoopharmacognosy Gorgio Samorini writes…
While the research on using psychedelics for the treatment of addiction is still in its early stages, findings are promising.
A recent series of case studies provided promising preliminary evidence for the potential of microdosing in treating chronic pain.
Microdosing refers to the practice of using psychedelics repeatedly below the threshold for perceptual alterations.
At the federal level, psilocybin in listed as a Schedule I drug. The use, sale, and possession of psilocybin in
To date, there is currently limited-to-no available evidence-based knowledge on dosage method comparisons for microdosing.
Currently, there is no empirical evidence available that supports the absorption of psychedelic compounds such as psilocybin through skin pores.
Psychedelic integration is a critical component of understanding and incorporating the knowledge and lessons gained during the psychedelic experience.
Join our email list and get immediate access to part one of our psilocybin guide. You’ll also get the latest in how we’re bridging the gap between science and soul: psychedelic research updates, real-world findings, community-driven education, personal stories and expert insights on natural medicine.
Advancing Real-World Psychedelic Research and Science-Backed Education
Unlimited Sciences is provided with a nonprofit status by fiscal sponsorship through Realm of Caring Foundation.
Federal EIN: 46-3371348.
© 2025 Unlimited Sciences. All Rights Reserved.
Designed by Gloss